Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
<p>Abstract</p> <p>Background</p> <p>The <it>enhancer of zeste homolog 2 </it>(<it>EZH2</it>) gene exerts oncogene-like activities and its (over)expression has been linked to several human malignancies. Here, we studied a possible association between EZH2 expression and prognosis in patients with re...
Сохранить в:
| Главные авторы: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2010-10-01
|
| Серии: | BMC Cancer |
| Online-ссылка: | http://www.biomedcentral.com/1471-2407/10/524 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|